Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Obstetrics/Gynecology (Women’s Health) | Family Medicine
Disease Category: Pregnancy Complications
Location: United States, FL
Drug to Prevent Pre-term Labor
This study is for women who are pregnant and have previously had a preterm birth. The study involves weekly injections of hydroxyprogesterone caproate starting at 16-20 weeks till 36 weeks or delivery. There is only one visit post-delivery which can be done by phone. The study drug is given at no cost to the participant. Patients are compensated $50 for the second visit and $25 for each subsequent visit ($500 total).
Patient Inclusion Criteria:
- are 16-20 weeks pregnant
- previously had a preterm birth (born less than 37 weeks)
Patient Exclusion Criteria:
- expecting twins, triplets, etc.
- been on heparin or progesterone treatment during pregnancy
Rossmeri Montalvo, Site Director
4671 S. Congress Ave
Lake Worth, FL 33461
Phone: (561) 641-0404
Fax: (561) 641-0345
Research Center Information: Altus Research
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these